Roth Capital Previews Preclinical PRESERVATION-1 Data; Affirms BioLineRx (BLRX) at 'Buy'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.04 -0.02 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.06 | 52 Week High | $1.63 | |||
| Open | $2.04 | 52 Week Low | $0.71 | |||
| Day High | $2.11 | P/E | N/A | |||
| Day Low | $2.04 | EPS | $0.00 | |||
| Volume | 1,703 | |||||
